Putting the Patient at the Center of Rare Disease Clinical Trials

Scott Schliebner, senior vice president and head of the Center for Rare Diseases at PRA Health Sciences, discusses designing patient-centric clinical trials, why it matters, and what sponsors can do to stay focused on patients. @globalgenes #RARECast